IKK classic hereby announces that it will conclude non-exclusive discount agreements with all interested and suitable pharmaceutical companies in the period from 01.11.2023 to 31.10.2025 for various active ingredients and combinations of active ingredients in accordance with § 130a para. 8 SGB V on the same, non-negotiable conditions. The earliest start date of the contract is 01.11.2023, provided that the signed contract and all necessary evidence, self-declarations and documents are received by IKK classic by 05.10.2023. Thereafter, the following applies: If the documents are received by the 5th of each month in the possible accession period, the 1st of the following month will be the start of the contract. If the documents are received after the 5th of each month in the possible accession period, the 1st of the month after next will be the start of the contract. Joining the agreement is possible at any time during the specified period, but no later than 05.09.2025. For further information, see point VI.3).

Tocilizumab; ATC code: L04AC07